Question 14539 — pharmacy and medications

Summary

Mr. Nicolas Ray draws the attention of the Minister of Health, Families, Autonomy and Disabled People to the worrying increase in drug fraud on the national territory. Many community pharmacists report an increase in fraudulent practices which are no longer isolated incidents, but are now part of structured and organized operating methods. These actions are based in particular on group travel with distribution of roles, the use of multiple prescriptions in different pharmacies in order to circumvent controls, as well as on identity theft through the use of certificates of rights belonging to third parties. They also rely on specific administrative situations, such as the absence of a vital card or the use of social security numbers. provisional, making the traceability of deliveries more difficult. These networks target in particular certain drugs with high value or supply shortages, in particular antidiabetic treatments such as GLP-1 analogues, insulins or even blood sugar measuring devices, which accentuates the difficulties of access for patients who really need them. Recent situations, reported by health professionals, illustrate the scale of the phenomenon, with financial losses reaching several hundred thousand euros at the national level contributing to widening the already significant health insurance deficit. Despite a significant number of reports recorded on monitoring tools such as the ASAFO system, these tools present significant limits in their operation, to the extent that they can engage the liability of the pharmacist in the event of dispensing despite a report, thus exposing professionals to a high financial risk and increasing legal insecurity. Thus, these practices generate constant pressure on pharmacy teams, a deterioration of the relationship of trust with patients and, more broadly, a deterioration of working conditions. They intervene, moreover, in a a context already weakened by falling margins, increasing costs, recruitment difficulties and increasingly frequent supply disruptions in pharmacies, particularly in rural areas. It is urgent to provide concrete responses to these abuses, in order to guarantee both the security of the health system, the protection of professionals, equitable access to treatments for patients and the reduction of social security deficits. Faced with this situation, the MP asks what measures the Government intends to take to strengthen the fight against organized drug fraud networks. He also questions the envisaged adaptations of existing reporting tools so that they better protect pharmacists in the exercise of their missions, without placing a disproportionate financial risk on them.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.